We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$191M
Cap. Flow %
4.51%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$383M
2
DFS
Discover Financial Services
DFS
+$224M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$183M
4
WBA
Walgreens Boots Alliance
WBA
+$110M
5
JWN
Nordstrom
JWN
+$95.8M

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$235M
2
SMAR
Smartsheet Inc.
SMAR
+$216M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$144M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$103M
5
ALTR
Altair Engineering Inc
ALTR
+$97.9M

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVLV icon
151
Evolv Technologies
EVLV
$1.07B
$1.34M 0.03%
430,223
– –
IMCR icon
152
Immunocore
IMCR
$1.75B
$1.34M 0.03%
45,196
-78
-0.2% -$2.34K
DG icon
153
Dollar General
DG
$28.1B
$1.32M 0.03%
+15,000
New +$1.14M
BPMC
154
DELISTED
Blueprint Medicines
BPMC
$1.32M 0.03%
14,865
-5,268
-26% -$514K
INSP icon
155
Inspire Medical Systems
INSP
$1.7B
$1.27M 0.03%
+8,000
New +$1.45M
BCYC
156
Bicycle Therapeutics
BCYC
$278M
$1.26M 0.03%
148,722
+68,486
+85% +$807K
TMCI icon
157
Treace Medical Concepts
TMCI
$284M
$1.24M 0.03%
147,695
-126,505
-46% -$1.14M
XRX icon
158
PUT
Xerox
XRX
$424M
$1.22M 0.03%
278,300
– –
QURE icon
159
uniQure
QURE
$3.15B
$1.22M 0.03%
114,889
-77,334
-40% -$1.08M
SLNO
160
DELISTED
Soleno Therapeutics
SLNO
$1.22M 0.03%
17,022
+9,045
+113% +$440K
IR icon
161
Ingersoll Rand
IR
$34.2B
$1.2M 0.03%
+15,000
New +$1.31M
PTCT icon
162
PTC Therapeutics
PTCT
$5.91B
$1.19M 0.03%
23,353
-23,541
-50% -$1.17M
KROS icon
163
Keros Therapeutics
KROS
$211M
$1.18M 0.03%
115,518
+64,621
+127% +$750K
SDGR icon
164
Schrodinger
SDGR
$1.33B
$1.17M 0.03%
59,043
+12,129
+26% +$273K
MLYS icon
165
Mineralys Therapeutics
MLYS
$2.38B
$1.16M 0.03%
73,348
+45,280
+161% +$521K
DADA
166
DELISTED
Dada Nexus
DADA
$1.15M 0.03%
+618,986
New +$1.07M
IDYA icon
167
IDEAYA Biosciences
IDYA
$3.49B
$1.14M 0.03%
69,474
-3,242
-4% -$69.1K
ALCY
168
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$1.13M 0.03%
100,248
– –
DLTR icon
169
Dollar Tree
DLTR
$24.9B
$1.12M 0.03%
+14,900
New +$1.07M
HYAC
170
DELISTED
Haymaker Acquisition Corp 4
HYAC
$1.1M 0.03%
100,248
– –
VRNA
171
DELISTED
Verona Pharma
VRNA
$1.09M 0.03%
+17,150
New +$1.03M
TPR icon
172
Tapestry
TPR
$32.7B
$1.06M 0.03%
+15,000
New +$1.14M
NUVB icon
173
Nuvation Bio
NUVB
$2.13B
$1.04M 0.02%
+592,119
New +$1.35M
GAP
174
The Gap Inc
GAP
$7.39B
$1.03M 0.02%
+50,000
New +$1.12M
MRUS
175
DELISTED
Merus
MRUS
$1.02M 0.02%
24,232
+9,692
+67% +$423K
5 6
7
8 9

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor deployed $191M of net new capital in Q1 2025, opening 83 new positions and adding to 81 existing holdings. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Juniper Networks, an estimated $71.4M trimmed.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.